Orthopediatrics CORP Form 4 insider transactions

Squadron Capital LLC and 1 other reported changes in beneficial ownership of Orthopediatrics Corp common stock on September 10, 2026.

Jennifer N. Pritzker, a 10% owner of Orthopediatrics Corp, sold 302,369 shares of common stock on September 10, 2026 for $21.01 per share.

David R Pelizzon, a Director and 10% owner of Orthopediatrics Corp, sold 302,369 shares of common stock on September 10, 2026 for $21.01 per share.

Squadron Capital LLC and 1 other reported changes in beneficial ownership of Orthopediatrics Corp common stock on September 2, 2026.

Jennifer N. Pritzker, a 10% owner of Orthopediatrics Corp, sold 22,500 shares of common stock on September 2, 2026 for $23.35 per share.

David R Pelizzon, a Director and 10% owner of Orthopediatrics Corp, sold 22,500 shares of common stock on September 2, 2026 for $23.35 per share.

Squadron Capital LLC and 1 other reported changes in beneficial ownership of Orthopediatrics Corp common stock on August 28, 2026.

Jennifer N. Pritzker, a 10% owner of Orthopediatrics Corp, sold 336,831 shares of common stock on August 28, 2026.

David R Pelizzon, a Director and 10% owner of Orthopediatrics Corp, sold 336,831 shares of common stock on August 28, 2026.

Jennifer N. Pritzker, a 10% owner of Orthopediatrics Corp, sold 38,300 shares of common stock on August 24, 2026.

Squadron Capital LLC and 1 other reported changes in beneficial ownership of Orthopediatrics Corp common stock on August 24, 2026.

David R Pelizzon, a Director and 10% owner of Orthopediatrics Corp, sold 38,300 shares of common stock on August 24, 2026.

David R. Pelizzon, a Director at Orthopediatrics Corp., has acquired 11,436 shares of common stock.

Bryan W. Hughes, a Director at Orthopediatrics Corp., acquired 11,436 shares of common stock on June 9, 2026.

Orthopediatrics Corp Director Kelly Laine Fischer acquired 11,436 shares of common stock on June 9, 2026, as reported in a Form 4 filing.

Samuel D. Riccitelli, a Director at Orthopediatrics Corp., acquired 11,436 shares of common stock on June 9, 2026.

Orthopediatrics Corp. Director Harold Ruf reported a transaction involving common stock on June 9, 2026.

David R. Bailey, President and CEO of Orthopediatrics Corp., acquired 119,140 shares of common stock on June 9, 2026.

Orthopediatrics Corp. Director Jimmy Duane McDonald acquired 11,436 shares of common stock on June 9, 2026, as reported in a Form 4 filing.

Marie C. Infante (Reynolds), a Director at Orthopediatrics Corp., acquired 11,436 shares of common stock on June 9, 2026.

Mark C. Throdahl, a Director at Orthopediatrics Corp., reported the acquisition of 11,436 common shares on June 9, 2026.

Orthopediatrics Corp. Director George Sinclair Mitchell acquired 11,436 shares of common stock on June 9, 2026, increasing his direct beneficial ownership.

Daniel J. Gerritzen, General Counsel and Secretary of OrthoPediatrics Corp, reported a gift of 2,479 common shares.

Joseph W. Hauser, President of Trauma & Def. Correction at ORTHOPEDIATRICS CORP, reported acquiring 65,700 shares and selling 8,596 shares to cover tax obligations.

ORTHOPEDIATRICS Corp. COO and CFO Fred Hite reported the acquisition of 77,405 shares and the sale of 12,993 shares to cover tax obligations, as part of a pre-planned transaction.

ORTHOPEDIATRICS CORP's President and CEO, David R. Bailey, sold 19,535 common shares at $17.25 to cover tax obligations from restricted stock vesting.

Orthopediatrics' President of Scoliosis, Gregory A. Odle, sold 8,433 shares of common stock to cover tax withholding obligations following the vesting of restricted shares.

Orthopediatrics General Counsel Daniel J. Gerritzen reported an acquisition of shares followed by a sale to cover tax withholding obligations.

David R. Bailey, President and CEO of OrthoPediatrics Corp, reported gifting 1,600 shares of common stock on December 29, 2025.

ORTHOPEDIATRICS Corp. director Kelly Laine Fischer was granted 4,345 shares of common stock as part of her compensation for service.